Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.90 and traded as high as $6.34. Cipher Pharmaceuticals shares last traded at $6.20, with a volume of 14,385 shares traded.
Cipher Pharmaceuticals Stock Down 2.4 %
The firm’s fifty day simple moving average is $5.90 and its 200 day simple moving average is $4.70.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Further Reading
- Five stocks we like better than Cipher Pharmaceuticals
- Investing In Preferred Stock vs. Common Stock
- Comprehensive Analysis of PayPal Stock
- What Are Dividend Contenders? Investing in Dividend Contenders
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- What Investors Need to Know About Upcoming IPOs
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.